The global allergy treatment market is entering a period of sustained expansion, driven by an alarming rise in allergy prevalence worldwide and continuous advancements in medical therapeutics. The market, valued at US$ 18.9 Bn in 2023, is projected to grow at a CAGR of 5.8% from 2024 to 2034, ultimately reaching US$ 34.9 Bn by 2034. As lifestyle patterns shift, climates change, and pollution...